Sexual health outcomes after colorectal cancer diagnosis in females: a population-based cohort study

Niki Oveisi, Eric C Sayre, Lori A Brotto, Vicki Cheng, Vienna Cheng, Sharlene Gill, Gillian E Hanley, Helen McTaggart-Cowan, Stuart Peacock, Meera Rayar, Amirrtha Srikanthan, Dani Taylor, Mikaela Barnes, Mary A De Vera
{"title":"Sexual health outcomes after colorectal cancer diagnosis in females: a population-based cohort study","authors":"Niki Oveisi, Eric C Sayre, Lori A Brotto, Vicki Cheng, Vienna Cheng, Sharlene Gill, Gillian E Hanley, Helen McTaggart-Cowan, Stuart Peacock, Meera Rayar, Amirrtha Srikanthan, Dani Taylor, Mikaela Barnes, Mary A De Vera","doi":"10.1093/jnci/djaf120","DOIUrl":null,"url":null,"abstract":"Background Colorectal cancer (CRC) affects a growing number of females. Our objective was to evaluate the impact of CRC on sexual health outcomes among females, while controlling for age. Methods We conducted a cohort study using administrative health data from the province of British Columbia (BC) including linked health visits and cancer registry from 1985–2017. The cohort included females with CRC (n = 25,402; mean age (SD): 69.0 (13.1)) and matched controls without cancer (n = 254,020; 69.0 (13.1)) in a 1:10 ratio by age, further stratified by age groups (≤39 years and ≥40 years). Multivariable Cox regression models assessed the associations between CRC and five sexual health outcomes (dyspareunia, pelvic inflammatory disease, endometriosis, abnormal bleeding, and premature ovarian failure), adjusting for covariates. Sensitivity analyses focused on females with CRC to explore associations between sociodemographic and cancer-related factors and sexual health outcomes. Tests were 2-sided (statistical significance p-value < 0.05). Results Females with CRC had higher risks of dyspareunia (HR 1.67; 95% CI 1.62–1.73), pelvic inflammatory disease (HR 3.42; 95% CI: 3.07–3.81), and endometriosis (HR 1.95; 95% CI: 1.69 –2.25) compared to controls. In the ≥40-year group, these associations persisted, while in the ≤39-year group, endometriosis was not associated with CRC, but premature ovarian failure was (HR 1.75; 95% CI: 1.40–2.19). In sensitivity analyses, we also observed associations with cancer treatments (surgery, chemotherapy, radiation) and sexual health outcomes. Conclusions This population-based study identified associations between CRC and adverse sexual health outcomes among female patients, highlighting the need for targeted interventions and support.","PeriodicalId":501635,"journal":{"name":"Journal of the National Cancer Institute","volume":"182 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the National Cancer Institute","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jnci/djaf120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background Colorectal cancer (CRC) affects a growing number of females. Our objective was to evaluate the impact of CRC on sexual health outcomes among females, while controlling for age. Methods We conducted a cohort study using administrative health data from the province of British Columbia (BC) including linked health visits and cancer registry from 1985–2017. The cohort included females with CRC (n = 25,402; mean age (SD): 69.0 (13.1)) and matched controls without cancer (n = 254,020; 69.0 (13.1)) in a 1:10 ratio by age, further stratified by age groups (≤39 years and ≥40 years). Multivariable Cox regression models assessed the associations between CRC and five sexual health outcomes (dyspareunia, pelvic inflammatory disease, endometriosis, abnormal bleeding, and premature ovarian failure), adjusting for covariates. Sensitivity analyses focused on females with CRC to explore associations between sociodemographic and cancer-related factors and sexual health outcomes. Tests were 2-sided (statistical significance p-value < 0.05). Results Females with CRC had higher risks of dyspareunia (HR 1.67; 95% CI 1.62–1.73), pelvic inflammatory disease (HR 3.42; 95% CI: 3.07–3.81), and endometriosis (HR 1.95; 95% CI: 1.69 –2.25) compared to controls. In the ≥40-year group, these associations persisted, while in the ≤39-year group, endometriosis was not associated with CRC, but premature ovarian failure was (HR 1.75; 95% CI: 1.40–2.19). In sensitivity analyses, we also observed associations with cancer treatments (surgery, chemotherapy, radiation) and sexual health outcomes. Conclusions This population-based study identified associations between CRC and adverse sexual health outcomes among female patients, highlighting the need for targeted interventions and support.
女性结直肠癌诊断后的性健康结果:一项基于人群的队列研究
结直肠癌(CRC)影响越来越多的女性。我们的目的是评估结直肠癌对女性性健康结果的影响,同时控制年龄。方法:我们使用来自不列颠哥伦比亚省(BC)的行政卫生数据进行了一项队列研究,包括1985-2017年的相关健康访问和癌症登记。该队列包括患有结直肠癌的女性(n = 25402;平均年龄(SD): 69.0(13.1))和没有癌症的匹配对照(n = 254,020;69.0(13.1)),按年龄1:10的比例,进一步按年龄组(≤39岁和≥40岁)分层。多变量Cox回归模型评估了结直肠癌与五种性健康结局(性交困难、盆腔炎、子宫内膜异位症、异常出血和卵巢早衰)之间的关系,并对协变量进行了调整。敏感性分析以女性结直肠癌患者为研究对象,探讨社会人口学和癌症相关因素与性健康结局之间的关系。检验为双侧检验(p值&;lt;0.05)。结果女性结直肠癌患者发生性交困难的风险较高(HR 1.67;95% CI 1.62-1.73),盆腔炎(HR 3.42;95% CI: 3.07-3.81),子宫内膜异位症(HR 1.95;95% CI: 1.69 -2.25)。在≥40岁组中,这些关联持续存在,而在≤39岁组中,子宫内膜异位症与CRC无关,但卵巢早衰与CRC相关(HR 1.75;95% ci: 1.40-2.19)。在敏感性分析中,我们还观察到与癌症治疗(手术、化疗、放疗)和性健康结果的关联。结论:这项基于人群的研究确定了女性患者中结直肠癌与不良性健康结局之间的关联,强调了有针对性干预和支持的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信